1 results match your criteria: "New University of Lisbon and Centro Hospitalar de Lisboa[Affiliation]"
Long-term and concentration-dependent beneficial effect of efavirenz on HDL-cholesterol in HIV-infected patients.
Br J Clin Pharmacol
May 2006
Department of Pharmacology, Faculty of Medical Sciences, New University of Lisbon and Centro Hospitalar de Lisboa, Zona Central, Lisbon, Portugal.
Aims: To investigate the long-term effects of efavirenz on cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL-C) and triglycerides (TG).
Methods: Thirty-four HIV-infected patients who commenced efavirenz therapy were monitored for 36 months.
Results: In patients with baseline HDL-C<40 mg.